The Nasdaq composite is back in the green, up 0.7% from its intraday low, helped by the rally in Gilead Sciences (GILD +0.6%) on 30% higher volume on reports that
it is evaluating its experimental Ebola candidate, Nuc inhibitor
GS-5734, for the potential treatment of 2019-nCov infection, the
coronavirus causing the current outbreak in China.
https://seekingalpha.com/news/3534077-gilead-helps-nasdaq-rebound-on-coronavirus-news
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.